Healthy control for Cannabis Use Disorder

The Anlyan Center, New Haven, CT
Cannabis Use Disorder[18F]FPEB with PET - Drug
18 - 55
All Sexes

Study Summary

This trial will explore the link between cannabis use disorder, brain activity, and cognitive function to see how they affect each other.

Eligible Conditions
  • Cannabis Use Disorder

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase < 1

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline and Day 28

Baseline and Day 28
Change in Metabotropic Glutamate Receptor 5 (mGluR5) Availability
Change in Neurocognitive Function using CogState Cognitive Battery
Change in Verbal Memory measured using Electroencephalography (EEG)

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Healthy control
1 of 2
Cannabis use disorder
1 of 2

Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Healthy control · No Placebo Group · Phase < 1

Healthy control
Experimental Group · 1 Intervention: [18F]FPEB with PET · Intervention Types: Drug
Cannabis use disorderExperimental Group · 2 Interventions: [18F]FPEB with PET, Cannabis abstinence · Intervention Types: Drug, Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and day 28

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,729 Previous Clinical Trials
20,526,926 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,305 Previous Clinical Trials
2,022,933 Total Patients Enrolled
Stephen R Baldassarri, M.D.Principal InvestigatorYale University
1 Previous Clinical Trials
15 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You or your close family member has not been diagnosed with any mental illness, except for cannabis use in the case of those with Cannabis Use Disorder.
You have used cannabis less than 20 times in your entire life.
You have not used cannabis in the last two years according to your own statement.

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

Frequently Asked Questions

Am I a permissible participant for this clinical research?

"In order to be admitted into this medical trial, the subject must suffer from a cannabis use disorder and fall within the 18-55 years old age bracket. Approximately 60 individuals will receive admittance." - Anonymous Online Contributor

Unverified Answer

Is the current research open to those aged eighteen and over?

"Qualified participants must range between 18 and 55. Meanwhile, 15 trials are available for individuals under the age of majority while 49 offer treatment to those 65 or older." - Anonymous Online Contributor

Unverified Answer

Does this medical trial have any openings for participants?

"According to information hosted on, this trial has ceased recruiting patients since its last edit of December 22nd 2022 and is not currently seeking participants. Despite that, there are still 121 other medical studies actively welcoming volunteers for engagement in their trials." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.